$RGBP
Regen BioPharma Inc Stock $rgbp

$rgbp Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000160706223000371 Filed on July 25, 2023

Income Statement

Concept	2023 Q2	2022 Q2
Revenue	$59.07K	$31.29K
YoY Change	88.77%	7.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$99.22K	$86.57K
YoY Change	14.61%	2.0%
% of Gross Profit
Research & Development	$45.00K	$31.06K
YoY Change	44.88%	117.91%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$144.2K	$31.06K
YoY Change	364.31%	117.91%
Operating Profit	-$85.16K	-$58.91K
YoY Change	44.55%	38.64%
Interest Expense	-$14.06K	$30.40K
YoY Change	-146.25%	-48.97%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00
YoY Change
Pretax Income	-$99.22K	$66.96M
YoY Change	-100.15%	-994.07%
Income Tax
% Of Pretax Income
Net Earnings	-$99.22K	$66.96M
YoY Change	-100.15%	-994.07%
Net Earnings / Revenue	-167.97%	213978.54%
Basic Earnings Per Share	-$0.03
Diluted Earnings Per Share	-$0.03	$14.00K
COMMON SHARES
Basic Shares Outstanding	3.381M shares	3.189M shares
Diluted Shares Outstanding	3.381M shares

Balance Sheet

Concept	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$690.00	$111.0K
YoY Change	-99.38%	-41.02%
Cash & Equivalents	$692.00	$111.0K
Short-Term Investments
Other Short-Term Assets	$5.380K	$27.80K
YoY Change	-80.65%
Inventory
Prepaid Expenses	$377.00	$27.80K
Receivables	$56.55K	$295.5K
Other Receivables	$0.00	$6.020K
Total Short-Term Assets	$62.62K	$440.3K
YoY Change	-85.78%	16.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$222.6K	$249.4K
YoY Change	-10.76%	-76.35%
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$222.6K	$249.4K
YoY Change	-10.76%	-76.35%
TOTAL ASSETS
Total Short-Term Assets	$62.62K	$440.3K
Total Long-Term Assets	$222.6K	$249.4K
Total Assets	$285.2K	$689.7K
YoY Change	-58.65%	-51.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.40K	$28.80K
YoY Change	2.09%	-71.26%
Accrued Expenses	$1.630M	$2.004M
YoY Change	-18.69%	-12.72%
Deferred Revenue
YoY Change
Short-Term Debt	$101.7K	$1.230K
YoY Change	8169.11%	-91.92%
Long-Term Debt Due	$509.9K	$1.581M
YoY Change	-67.75%	-33.12%
Total Short-Term Liabilities	$5.314M	$9.039M
YoY Change	-41.21%	-34.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.314M	$9.039M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$5.314M	$9.039M
YoY Change	-41.21%	-34.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.42M	-$20.83M
YoY Change	-6.74%
Common Stock	$339.00	$492.0K
YoY Change	-99.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.029M	-$8.350M
YoY Change
Total Liabilities & Shareholders Equity	$285.2K	$689.7K
YoY Change	-58.65%	-51.89%

Cashflow Statement

Concept	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$99.22K	$66.96M
YoY Change	-100.15%	-994.07%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$87.01K	-$123.7K
YoY Change	-29.65%	93.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-87.01K	-123.7K
Cash From Investing Activities
Cash From Financing Activities	0.000	0.000
Net Change In Cash	-87.01K	-123.7K
YoY Change	-29.65%	-165.72%
FREE CASH FLOW
Cash From Operating Activities	-$87.01K	-$123.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001589150
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Interest Paid InterestPaid		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-191725
	dei	Entity Registrant Name EntityRegistrantName	REGEN BIOPHARMA, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-5192997
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4700 Spring Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	St 304
	dei	Entity Address City Or Town EntityAddressCityOrTown	La Mesa
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91942
	dei	City Area Code CityAreaCode	619
	dei	Local Phone Number LocalPhoneNumber	722-5505
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3381366	shares
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	us-gaap	Cash Cash	692	usd
CY2022Q3	us-gaap	Cash Cash	51204	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	56547	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	254273	usd
CY2023Q2	RGBP	Notes Receivable Related Party Current NotesReceivableRelatedPartyCurrent	0	usd
CY2022Q3	RGBP	Notes Receivable Related Party Current NotesReceivableRelatedPartyCurrent	0	usd
CY2023Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	0	usd
CY2022Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	0	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	377	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	20945	usd
CY2023Q2	us-gaap	Prepaid Rent PrepaidRent	5000	usd
CY2022Q3	us-gaap	Prepaid Rent PrepaidRent	10000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	62616	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	336422	usd
CY2022Q3	RGBP	Available For Sale Securitie AvailableForSaleSecuritie	0	usd
CY2023Q2	RGBP	Investment Securities Related Party InvestmentSecuritiesRelatedParty	222580	usd
CY2022Q3	RGBP	Investment Securities Related Party InvestmentSecuritiesRelatedParty	222580	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	222580	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	222580	usd
CY2023Q2	us-gaap	Assets Assets	285196	usd
CY2022Q3	us-gaap	Assets Assets	559002	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	29403	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	28799	usd
CY2023Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	100710	usd
CY2022Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	710	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4241	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4241	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	327511	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	689785	usd
CY2023Q2	RGBP	Accrued Rent AccruedRent	0	usd
CY2022Q3	RGBP	Accrued Rent AccruedRent	0	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1256630	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1266679	usd
CY2023Q2	RGBP	Other Accrued Expenses OtherAccruedExpenses	41423	usd
CY2022Q3	RGBP	Other Accrued Expenses OtherAccruedExpenses	41423	usd
CY2023Q2	us-gaap	Bank Overdrafts BankOverdrafts	1000	usd
CY2022Q3	us-gaap	Bank Overdrafts BankOverdrafts	1000	usd
CY2023Q2	RGBP	Due To Investor DueToInvestor	20000	usd
CY2022Q3	RGBP	Due To Investor DueToInvestor	20000	usd
CY2023Q2	RGBP	Unearned Income UnearnedIncome	1623370	usd
CY2022Q3	RGBP	Unearned Income UnearnedIncome	1718290	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1400000	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	3551793	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	499880	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1262340	usd
CY2023Q2	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount	10000	usd
CY2022Q3	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount	10000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5314169	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8595061	usd
CY2023Q2	us-gaap	Liabilities Liabilities	5314169	usd
CY2022Q3	us-gaap	Liabilities Liabilities	8595061	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5800000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5800000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3354866	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3381366	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	339	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	503150	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13658153	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11581499	usd
CY2023Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	736326	usd
CY2022Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	736326	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19423836	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20905369	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5028973	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8036059	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	285196	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	559002	usd
CY2023Q2	us-gaap	Revenues Revenues	31640	usd
CY2022Q2	us-gaap	Revenues Revenues	31292	usd
	us-gaap	Revenues Revenues	94920	usd
	us-gaap	Revenues Revenues	93877	usd
CY2023Q2	RGBP	Revenues Related Party RevenuesRelatedParty	27425	usd
CY2022Q2	RGBP	Revenues Related Party RevenuesRelatedParty	27425	usd
	RGBP	Revenues Related Party RevenuesRelatedParty	82274	usd
	RGBP	Revenues Related Party RevenuesRelatedParty	82274	usd
CY2023Q2	RGBP	Total Revenues TotalRevenues	59065	usd
CY2022Q2	RGBP	Total Revenues TotalRevenues	58717	usd
	RGBP	Total Revenues TotalRevenues	177194	usd
	RGBP	Total Revenues TotalRevenues	176151	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45001	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31061	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	176960	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	93869	usd
CY2023Q2	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	0	usd
CY2022Q2	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	0	usd
	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	0	usd
	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	117250	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9262	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6866	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36660	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18879	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	74957	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	64700	usd
	us-gaap	Professional Fees ProfessionalFees	546437	usd
	us-gaap	Professional Fees ProfessionalFees	152979	usd
CY2023Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15000	usd
CY2022Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	45000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	35000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	144220	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	117627	usd
	us-gaap	Costs And Expenses CostsAndExpenses	805057	usd
	us-gaap	Costs And Expenses CostsAndExpenses	417977	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-85155	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-58910	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-627863	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-241826	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	0	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	133	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	0	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	399	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	14063	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	30399	usd
	us-gaap	Interest Expense InterestExpense	43507	usd
	us-gaap	Interest Expense InterestExpense	107970	usd
CY2023Q2	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	0	usd
CY2022Q2	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-22203	usd
	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	0	usd
	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-66631	usd
CY2023Q2	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	-0	usd
	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	-0	usd
	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	300000	usd
CY2023Q2	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	0	usd
CY2022Q2	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	161729	usd
	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	0	usd
	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	31433	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2023Q2	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	0	usd
CY2022Q2	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	0	usd
	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	0	usd
	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	62700	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	66907817	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2151755	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3238473	usd
CY2023Q2	RGBP	Financing Fees FinancingFees	0	usd
CY2022Q2	RGBP	Financing Fees FinancingFees	0	usd
	RGBP	Financing Fees FinancingFees	0	usd
	RGBP	Financing Fees FinancingFees	0	usd
CY2023Q2	RGBP	Legal Settlement LegalSettlement	0	usd
CY2022Q2	RGBP	Legal Settlement LegalSettlement	0	usd
	RGBP	Legal Settlement LegalSettlement	0	usd
	RGBP	Legal Settlement LegalSettlement	0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1150	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-95019	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-14063	usd
CY2022Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	67017077	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2109397	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2763385	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-99218	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	66958167	usd
	us-gaap	Net Income Loss NetIncomeLoss	1481534	usd
	us-gaap	Net Income Loss NetIncomeLoss	2521557	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99218	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	60931931.00	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1303750	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2294618	usd
CY2023Q2	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	-0.03
CY2022Q2	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	19.11
	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	0.39
	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	0.72
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3381366	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3189187	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3370012	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3196085	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-13485877	usd
CY2021Q4	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	26662	usd
CY2021Q4	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	38837	usd
CY2021Q4	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	19603	usd
CY2021Q4	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	18575	usd
CY2021Q4	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	75000	usd
CY2021Q4	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	32075	usd
CY2021Q4	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	10356	usd
CY2021Q4	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value7 SharesIssuedForInterestValue7	8883	usd
CY2021Q4	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value8 SharesIssuedForInterestValue8	23369	usd
CY2021Q4	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value9 SharesIssuedForInterestValue9	39808	usd
CY2021Q4	RGBP	Shares Issued For Debt8 Amount SharesIssuedForDebt8Amount	40000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value10 SharesIssuedForInterestValue10	14192	usd
CY2021Q4	RGBP	Shares Issued For Debt9 Amount SharesIssuedForDebt9Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value11 SharesIssuedForInterestValue11	19012	usd
CY2021Q4	RGBP	Shares Issued For Debt10 Amount SharesIssuedForDebt10Amount	10964	usd
CY2021Q4	RGBP	Shares Issued For Debt11 Amount SharesIssuedForDebt11Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value12 SharesIssuedForInterestValue12	11527	usd
CY2021Q4	RGBP	Shares Issued For Debt12 Amount SharesIssuedForDebt12Amount	60000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value13 SharesIssuedForInterestValue13	25440	usd
CY2021Q4	RGBP	Shares Issued For Debt13 Amount SharesIssuedForDebt13Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value14 SharesIssuedForInterestValue14	10625	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	2644980	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9755969	usd
CY2022Q1	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	48420	usd
CY2022Q1	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	39708	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-67081589	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-76749430	usd
CY2022Q2	RGBP	Shares Issued For Debt20 Amount SharesIssuedForDebt20Amount	218617	usd
CY2022Q2	RGBP	Shares Issued For Interest Value15 SharesIssuedForInterestValue15	1701	usd
CY2022Q2	RGBP	Shares Issued For Debt15 Amount SharesIssuedForDebt15Amount	550161	usd
CY2022Q2	RGBP	Shares Issued For Interest Value16 SharesIssuedForInterestValue16	1500	usd
CY2022Q2	RGBP	Shares Issued For Debt16 Amount SharesIssuedForDebt16Amount	334800	usd
CY2022Q2	RGBP	Shares Issued For Debt17 Amount SharesIssuedForDebt17Amount	334800	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	66958167	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-8349684	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8036059	usd
CY2022Q4	RGBP	Preferred Shares Issued For Nonemployee Services PreferredSharesIssuedForNonemployeeServices	300000	usd
CY2022Q4	RGBP	Preferred Shares Issued For Debt PreferredSharesIssuedForDebt	761500	usd
CY2022Q4	RGBP	Preferred Shares Issued For Interest PreferredSharesIssuedForInterest	380262	usd
CY2022Q4	RGBP	Common Shares Issued For Interest CommonSharesIssuedForInterest	25369	usd
CY2022Q4	RGBP	Preferred Shares Issued For Nonemployee Services1 PreferredSharesIssuedForNonemployeeServices1	48372	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1635730	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4884827	usd
CY2023Q1	RGBP	Reverse Stock Split Value ReverseStockSplitValue	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	10050	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-54978	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4929755	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-99218	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5028973	usd
	us-gaap	Net Income Loss NetIncomeLoss	1481534	usd
	us-gaap	Net Income Loss NetIncomeLoss	2521557	usd
	RGBP	Preferred Stock Issued As Compensation PreferredStockIssuedAsCompensation	-348372	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	66631	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	604	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62705	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-197725	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	82275	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	43507	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	78996	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-25570	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-20343	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-2151755	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-3238473	usd
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-94920	usd
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-93877	usd
	RGBP	Increase Decrease In Penalties IncreaseDecreaseInPenalties	300000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	399	usd
	RGBP	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	1150	usd
	RGBP	Unrealized Lossgain On Investment Securities UnrealizedLossgainOnInvestmentSecurities	31433	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-150512	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-521634	usd
	RGBP	Increase Decrease In Convertible Notes Payable IncreaseDecreaseInConvertibleNotesPayable	-94535	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-94535	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-50512	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-616169	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51204	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	727162	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	692	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110993	usd
	RGBP	Common Shares Issued For Debt CommonSharesIssuedForDebt	2197782	usd
	RGBP	Preferred Share Issued For Debt PreferredShareIssuedForDebt	761500	usd
	RGBP	Preferred Share Issued For Debt PreferredShareIssuedForDebt	75000	usd
	us-gaap	Interest Paid InterestPaid	27473	usd
	RGBP	Common Shares Issued For Interests CommonSharesIssuedForInterests	25369	usd
	RGBP	Common Shares Issued For Interests CommonSharesIssuedForInterests	309379	usd
	RGBP	Preferred Shares Issued For Interests PreferredSharesIssuedForInterests	380262	usd
	RGBP	Preferred Shares Issued For Interests PreferredSharesIssuedForInterests	33994	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0518	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	9.0761	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure
	us-gaap	Advertising Expense AdvertisingExpense	0	usd
	RGBP	Net Income Loss Since Inception NetIncomeLossSinceInception	19423836	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5800000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3381366	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares

Files In Submission

Name	View Source	Status
0001607062-23-000371-index-headers.html	Edgar Link	pending
0001607062-23-000371-index.html	Edgar Link	pending
0001607062-23-000371.txt	Edgar Link	pending
0001607062-23-000371-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rgbp-20230331.xsd	Edgar Link	pending
rgbp063023form10q.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rgbp-20230331_def.xml	Edgar Link	unprocessable
rgbp-20230331_lab.xml	Edgar Link	unprocessable
rgbp-20230331_pre.xml	Edgar Link	unprocessable
rgbp063023form10q_htm.xml	Edgar Link	completed
rgbp-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGBP
Regen BioPharma Inc Stock $rgbp

2023 Q2 Form 10-Q Financial Statement

#000160706223000371 Filed on July 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGBP Regen BioPharma Inc Stock $rgbp

2023 Q2 Form 10-Q Financial Statement

#000160706223000371 Filed on July 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGBP
Regen BioPharma Inc Stock $rgbp